Sijia Qiu, MS

Kaiser Permanente Southern California
Pasadena, California, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 784 - Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study

  Thursday, October 20, 2022
  4:00 PM – 4:15 PM US ET